{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:58Z","timestamp":1792184698235,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:00:00Z","timestamp":1339459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10354-012-0116-x","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T16:43:05Z","timestamp":1339432985000},"page":"374-379","source":"Crossref","is-referenced-by-count":3,"title":["Update on denosumab in postmenopausal osteoporosis\u2014recent clinical data","Densoumab bei postmenopausaler Osteoporose \u2013 rezente klinische Daten"],"prefix":"10.1007","volume":"162","author":[{"given":"Christian","family":"Muschitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Fahrleitner-Pammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Preisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kudlacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,12]]},"reference":[{"key":"116_CR1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"P Sambrook","year":"2006","unstructured":"Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367:2010\u20138.","journal-title":"Lancet."},{"key":"116_CR2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","volume":"375","author":"RM Zebaze","year":"2010","unstructured":"Zebaze RM, Ghasem-Zadeh A, Bohte A, et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010;375:1729\u201336.","journal-title":"Lancet."},{"key":"116_CR3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726\u201333.","journal-title":"Osteoporos Int."},{"key":"116_CR4","unstructured":"Dempster DW. Primer on the metabolic bone diseases and disorders of bone metabolism. 7th ed. ASBMR: Washington; 2008. pp.\u00a07\u201311."},{"key":"116_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337\u201342.","journal-title":"Nature."},{"issue":"Suppl","key":"116_CR6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","volume":"9","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl\u00a01):S1\u2013S7.","journal-title":"Arthritis Res Ther."},{"key":"116_CR7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-11-0454","volume":"165","author":"E Tsourdi","year":"2011","unstructured":"Tsourdi E, Rachner TD, Rauner M, et al. Denosumab for bone diseases: translating bone biology into targeted therapy. Eur J Endocrinol. 2011;165:833\u201340.","journal-title":"Eur J Endocrinol."},{"key":"116_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/11203300-000000000-00000","volume":"28","author":"MD Moen","year":"2011","unstructured":"Moen MD, Keam SJ. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging. 2011;28:63\u201382.","journal-title":"Drugs Aging."},{"key":"116_CR9","unstructured":"Denosumab (Prolia\u00ae) Summary of product characteristics. Amgen Inc."},{"issue":"4","key":"116_CR10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 2011;48(4):677\u201392.","journal-title":"Bone."},{"key":"116_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RGG Russell","year":"2007","unstructured":"Russell RGG, Xia Z, Dunford JE, et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann NY Acad Sci. 2007;1117:209\u201357.","journal-title":"Ann NY Acad Sci."},{"key":"116_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","volume":"360","author":"RS Weinstein","year":"2009","unstructured":"Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med. 2009;360:53\u201362.","journal-title":"N Engl J Med."},{"key":"116_CR13","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","volume":"86","author":"DB Kimmel","year":"2007","unstructured":"Kimmel DB. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res. 2007;86:1022\u201333.","journal-title":"J Dent Res."},{"key":"116_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","volume":"25","author":"DL Kendler","year":"2010","unstructured":"Kendler DL, Roux C, Benhamou CL, et al. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res. 2010;25:72\u201381.","journal-title":"J Bone Miner Res."},{"key":"116_CR15","unstructured":"Seeman E, Libanati C, Austin M, et al. The transitory increase in PTH following denosumab administration is associated with reduced intracortical porosity: a distinctive attribute of denosumab therapy. J Bone Mineral Res. 2011;26(Suppl\u00a01):S22, #1064."},{"key":"116_CR16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, Martin JS, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756\u201365.","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"116_CR17","first-page":"357","volume":"21","author":"R Rizzoli","year":"2010","unstructured":"Rizzoli R, Boonen S, Bone HG, et al. The effect of denosumab on vertebral fracture risk by type and subgroup: results from the FREEDOM trial. Osteoporosis Int. 2010;21(Suppl\u00a01):357\u20138 (Abstract P841).","journal-title":"Osteoporosis Int."},{"key":"116_CR18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/jc.2010-2784","volume":"96","author":"S Boonen","year":"2011","unstructured":"Boonen S, Adachi JD, Man Z, et al. Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metab. 2011;96:1727\u201336.","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl","key":"116_CR19","first-page":"S20","volume":"26","author":"J Simon","year":"2011","unstructured":"Simon J, Recknor C, Moffet A, et al. Effects of Denosumab on radius BMD, strength, and wrist fractures: results from theFractureReductionEvaluation ofDenosumab inOsteoporosis Every 6Months (FREEDOM) Study. J Bone Mineral Res. 2011;26(Suppl\u00a01):S20\u201321, #1062.","journal-title":"J Bone Mineral Res."},{"key":"116_CR20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","volume":"27","author":"S Papapoulos","year":"2012","unstructured":"Papapoulos S, Chapurlat R, Libanati C, et al. Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res. 2012;27:694\u2013701.","journal-title":"J Bone Miner Res."},{"issue":"Suppl","key":"116_CR21","first-page":"S22","volume":"26","author":"HG Bone","year":"2011","unstructured":"Bone HG, Chapurlat R, Libanati C, et al. Safety observations from denosumab long-term extension and cross-over studies in postmenopausal women with osteoporosis. J Bone Mineral Res. 2011;26(Suppl\u00a01):S22\u201323, #1065.","journal-title":"J Bone Mineral Res."},{"key":"116_CR22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","volume":"43","author":"PD Miller","year":"2008","unstructured":"Miller PD, Bolognese MA, Lewiecki EM, et al. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone. 2008;43:222\u20139.","journal-title":"Bone."},{"key":"116_CR23","doi-asserted-by":"crossref","unstructured":"McClung MR, Lewiecki EM, Bolognese MA, et al. Effects of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial. J Bone Min Res. 2011;26:Abstract 1061.","DOI":"10.1016\/j.yend.2011.04.023"},{"key":"116_CR24","unstructured":"Orwoll E, Stubbe Teglbj\u00e6rg C, Langdahl B, et al. A phase 3 Study of the efficacy and safety of denosumab in men with low bone mineral density: design of the ADAMO trial. J Bone Mineral Res. 2011;26(Suppl\u00a01):#MO0442."}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-012-0116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-012-0116-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-012-0116-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T18:16:59Z","timestamp":1561832219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-012-0116-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,12]]},"references-count":24,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1007\/s10354-012-0116-x","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,12]]}}}